Therapeutic Programs Powered by the KAS Discovery Engine™
Current Development Programs
While each program is at a different stage of development, they all contribute to our long-term vision of building a sustainable AI-enabled biotechnology innovation company.
| Program | Focus Area | Stage |
|---|---|---|
| GPCR Agricultural Biotechnology | Crop Protection & Nematode Biology | Preclinical Research |
| AI-Driven Drug Discovery | Computational Platform | Platform Development |
GPCR-Targeted Anthelmintic Therapeutics
Focus Area
Our lead therapeutic program focuses on developing GPCR-targeted anthelmintic therapeutics for the control of parasitic nematodes, with potential applications in agriculture, livestock, companion animal health, and human medicine.
Commercialization Strategy
Our initial commercialization strategy focuses on agricultural applications, providing an efficient pathway for proof of concept while establishing the scientific and commercial foundation for future veterinary and human therapeutic development.
Future Therapeutic Programs
Overview
Our AI-powered discovery platform is designed to accelerate the identification, screening, and optimization of promising therapeutic compounds from large chemical libraries across multiple disease areas.
Current Application & Pipeline Expansion
The platform is currently being applied to discover novel therapeutics for neurodegenerative diseases while providing a flexible foundation for future drug discovery programs spanning human medicine, animal health, and agriculture. As new biological insights emerge, it will continue to generate new therapeutic opportunities and expand the KASBioInnovations pipeline.